We are international
Donate
• about myeloma TEXT SIZE   


Myeloma Minute
June 12, 2014
06.12.14
June 12, 2014
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
 



This week's question: Are clinical trials part of the Black Swan Research Initiative, and if so, how can I participate?



Upcoming Events
 

Wednesday, June 18, 2014
7pm ET/ 4 pm PT
Raise Your Voice Web Series: Advocacy 202

Join us for a training webinar that will teach you how to schedule a meeting with your congressional representative and what to say during it, questions to ask at a town hall meeting, and how to build relationships with your representatives. Together we can help cancer patients gain affordable access to the treatments they need.

Saturday, June 14, 2014
Myeloma Center Workshop
Minneapolis, Minnesota

Monday, June 23, 2014
Onyx Team Bike Ride

Thursday, June 26, 2014
7 pm ET/ 4 pm PT
Post ASCO/EHA/IMWG Teleconference
Hosted by Dr. Durie

Myeloma Minute: Special Edition - the IMF in Milan!

This special edition of the Myeloma Minute comes to you from Milan, Italy, where the IMF's International Myeloma Working Group (IMWG) convened this week on the eve of the 19th Annual Congress of the European Hematology Association (EHA).
x
IMWG Summit - Live from Milan

The 5th Annual International Myeloma Working Group (IMWG) Summit was held in Milan, Italy this week, drawing a record number of myeloma researchers from around the world. Presentations of the latest myeloma data on topics such as new diagnostic criteria, advances in flow technology, and geriatric risk stratification were followed by energetic question and answer sessions between audience members and panelists. During intimate breakout discussions, myeloma specialists debated new ideas in depth and identified which ideas merited future study.

On June 26th, IMF Chairman Dr. Brian Durie will present a teleconference summarizing the myeloma news from the IMWG Summit, as well as news from the recent annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, and the annual congress of the EHA. Archived Tweets from #IMWG14 can be found HERE.
x
Antonio Palumbo Honored with the 2014 Robert A. Kyle Lifetime Achievement Award

Dr. Antonio Palumbo, Chief of the Myeloma Unit of the Department of Oncology, Division of Hematology at the University of Torino in Torino, Italy, was honored with the IMF's 12th Annual Robert A. Kyle Lifetime Achievement Award on June 10th. The award is given each year in recognition of outstanding work in the field of multiple myeloma. "Congratulations and thank you for your commitment to patients," said Susie Novis, IMF President. "Your leadership, innovation, and research have made a difference in the lives of patients and their families."

The gala dinner was held at Milan's Museo Nazionale Scienza e Tecnologia, Leonardo Da Vinci. Dr. Vincent Rajkumar lauded Dr. Palumbo for leading "important trials that have yielded incredible information." On receiving the award from its namesake, Dr. Robert Kyle, Dr. Palumbo noted that "less than 14 years ago, the median survival for myeloma was 29 months. Now we are projecting median survival of 7-10 years – triple the survival in 15 years!" No other cancer has seen that kind of progress, he said, adding that he would share the prize with his hard-working team.
x
Watch an Archive of the IMWG's Popular Conference Series, "Making Sense of Treatment"
An archived version of "Making Sense of Treatment," the International Myeloma Working Group (IMWG) Conference Series webcast from the 2014 IMWG Summit in Milan, is now available. During this exciting panel, leading experts Drs. Brian Durie, Ola Landgren, Joseph Mikhael, Antonio Palumbo, and Stephen Russell discussed and debated the latest trends in myeloma treatment. WATCH HERE
x
IMF Forms Affiliation with the Korea Blood Cancer Association
During the IMWG Summit in Milan, the IMF and the Korea Blood Cancer Association (KBCA) signed an affiliate agreement that will enable the two organizations to work closely together to support myeloma patients in Korea, increase myeloma awareness, improve patient access to treatment, and collaborate on myeloma research. The IMF collaborates with several affiliate organizations to support myeloma patients around the world. READ MORE
x
IMF's Nurse Leadership Board Members Publish Article
Members of the IMF's Nurse Leadership Board (NLB) have published a review article, "Innovative Agents in Multiple Myeloma," in the prestigious peer-reviewed Journal of the Advanced Practitioner in Oncology. In the article, Beth Faiman, PhDc, MSN, APN-BC, AOCN®, of the Cleveland Clinic, and Tiffany Richards, MS, ANP, AOCNP®, of the University of Texas MD Anderson Cancer Center, provide an overview of new targeted myeloma therapies that have shown activity in patients with relapsed and/or refractory myeloma. READ MORE
 

Join Our Mailing List

 
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe 
www.myeloma.org

 related articles